nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer
|
Wu, Yuanli |
|
|
65 |
C |
p. |
artikel |
2 |
An antibody targeting an immune checkpoint molecule BTN2A2 enhances anti-tumor immunity
|
Xiao, Li |
|
|
65 |
C |
p. |
artikel |
3 |
Corrigendum to “Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer” [Neoplasia. 2014 Aug;16(8):665-77]
|
Zhang, Tao |
|
|
65 |
C |
p. |
artikel |
4 |
Corrigendum to “PRMT1 methylates METTL14 to modulate its oncogenic function” [Neoplasia 42 (2023) 100912]
|
Wang, Jingchao |
|
|
65 |
C |
p. |
artikel |
5 |
DNA-methylation eraser TET2 activates WTIP expression to suppress an AKT-dependent chemoresistance of gastric cancer
|
Guo, Yan |
|
|
65 |
C |
p. |
artikel |
6 |
Establishment of patient-derived 3D in vitro models of sarcomas: literature review and guidelines on behalf of the FORTRESS working group
|
De Cock, Lore |
|
|
65 |
C |
p. |
artikel |
7 |
High metastatic tumor-derived CXCL16 mediates liver colonization metastasis by inducing Kupffer cell polarization via the PI3K/AKT/FOXO3a pathway
|
Liu, Yin |
|
|
65 |
C |
p. |
artikel |
8 |
Response of GEM models of neuroblastoma to cabozantinib assessed by multiparametric magnetic resonance imaging
|
Almeida, Gilberto S. |
|
|
65 |
C |
p. |
artikel |